Cargando…

An empirical pipeline for personalized diagnosis of Lafora disease mutations

Lafora disease (LD) is a fatal childhood dementia characterized by progressive myoclonic epilepsy manifesting in the teenage years, rapid neurological decline, and death typically within ten years of onset. Mutations in either EPM2A, encoding the glycogen phosphatase laforin, or EPM2B, encoding the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brewer, M. Kathryn, Machio-Castello, Maria, Viana, Rosa, Wayne, Jeremiah L., Kuchtová, Andrea, Simmons, Zoe R., Sternbach, Sarah, Li, Sheng, García-Gimeno, Maria Adelaida, Serratosa, Jose M., Sanz, Pascual, Vander Kooi, Craig W., Gentry, Matthew S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564118/ https://www.ncbi.nlm.nih.gov/pubmed/34755096 http://dx.doi.org/10.1016/j.isci.2021.103276

Ejemplares similares

Lafora Disease: A Ubiquitination-Related Pathology
por: García-Gimeno, Maria Adelaida, et al.
Publicado: (2018)

Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease
por: Sanz, Pascual, et al.
Publicado: (2021)

Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model
por: Moreno-Estellés, Mireia, et al.
Publicado: (2023)

A PTG Variant Contributes to a Milder Phenotype in Lafora Disease
por: Guerrero, Rosa, et al.
Publicado: (2011)

Identification of proteins potentially involved in the formation of Lafora bodies, a hallmark of Lafora disease
por: Schokraie, Elham, et al.
Publicado: (2013)

2348 Lafora disease premature termination codons (PTCs) are likely candidates for suppression by aminoglycosides
por: Simmons, Zoe R., et al.
Publicado: (2018)

Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data
por: Pondrelli, Federica, et al.
Publicado: (2023)

Lafora disease E3-ubiquitin ligase malin is related to TRIM32 at both the phylogenetic and functional level
por: Romá-Mateo, Carlos, et al.
Publicado: (2011)

Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease
por: Burgos, Daniel F., et al.
Publicado: (2020)

Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model
por: Mollá, Belén, et al.
Publicado: (2022)

Ketogenic diet reduces Lafora bodies in murine Lafora disease
por: Israelian, Lori, et al.
Publicado: (2020)

Laforin, a Dual Specificity Phosphatase Involved in Lafora Disease, Is Present Mainly as Monomeric Form with Full Phosphatase Activity
por: Dukhande, Vikas V., et al.
Publicado: (2011)

Everolimus does not prevent Lafora body formation in murine Lafora disease
por: Mishra, Navin, et al.
Publicado: (2017)

Reactive Glia Inflammatory Signaling Pathways and Epilepsy
por: Sanz, Pascual, et al.
Publicado: (2020)

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011)

Laforin, the most common protein mutated in Lafora disease, regulates autophagy
por: Aguado, Carmen, et al.
Publicado: (2010)

Unusual Course of Lafora Disease
por: Zutt, Rodi, et al.
Publicado: (2016)

Increased Endoplasmic Reticulum Stress and Decreased Proteasomal Function in Lafora Disease Models Lacking the Phosphatase Laforin
por: Vernia, Santiago, et al.
Publicado: (2009)

Trehalose Treatment in Zebrafish Model of Lafora Disease
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism
por: Couarch, Philippe, et al.
Publicado: (2011)

Glial Contributions to Lafora Disease: A Systematic Review
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

Structure-Function Analysis of PPP1R3D, a Protein Phosphatase 1 Targeting Subunit, Reveals a Binding Motif for 14-3-3 Proteins which Regulates its Glycogenic Properties
por: Rubio-Villena, Carla, et al.
Publicado: (2015)

Lafora Disease Masquerading as Hepatic Dysfunction
por: Inayat, Faisal, et al.
Publicado: (2018)

Lafora disease in miniature Wirehaired Dachshunds
por: Swain, Lindsay, et al.
Publicado: (2017)

Retinal alterations in patients with Lafora disease
por: Heitkotter, Heather, et al.
Publicado: (2021)

Lafora disease: a case report
por: Zeka, Naim, et al.
Publicado: (2022)

Electro-clinical features and management of the late stage of Lafora disease
por: d'Orsi, Giuseppe, et al.
Publicado: (2022)

Vagus nerve stimulation in Lafora body disease()
por: Hajnsek, Sanja, et al.
Publicado: (2013)

Treatment with metformin in twelve patients with Lafora disease
por: Bisulli, Francesca, et al.
Publicado: (2019)

Lafora Disease: Report of a Rare Entity
por: Al Mufargi, Younis, et al.
Publicado: (2020)

The Laforin–Malin Complex, Involved in Lafora Disease, Promotes the Incorporation of K63-linked Ubiquitin Chains into AMP-activated Protein Kinase β Subunits
por: Moreno, Daniel, et al.
Publicado: (2010)

Genetics of Lafora progressive myoclonic epilepsy: current perspectives
por: Kecmanović, Miljana, et al.
Publicado: (2016)

Extraneurological sparing in long‐lived typical Lafora disease
por: Goldsmith, Danielle, et al.
Publicado: (2018)

Genotypes and phenotypes of patients with Lafora disease living in Germany
por: Brenner, David, et al.
Publicado: (2019)

Canine Lafora Disease: An Unstable Repeat Expansion Disorder
por: von Klopmann, Thilo, et al.
Publicado: (2021)

Retinal Phenotyping of a Murine Model of Lafora Disease
por: Vincent, Ajoy, et al.
Publicado: (2023)

Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease
por: d'Orsi, Giuseppe, et al.
Publicado: (2023)

Age-Related microRNA Overexpression in Lafora Disease Male Mice Provides Links between Neuroinflammation and Oxidative Stress
por: Romá-Mateo, Carlos, et al.
Publicado: (2023)

Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities
por: Sanz, Pascual, et al.
Publicado: (2020)

TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases
por: Kumarasinghe, Lorena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_efqsj8kd037vcq5qji89rbncs9